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ABSTRACT  
For selective and effective drug delivery of therapeutic agent nanocarriers are the most effective agents. Micelles are an ag gregate of surfactant 
molecules that dispersed in a liquid colloid. Micelles have a variety of shapes such as spheres, rods, vesicles, tubules, and lamellae. The shape 
and size of a micelle are a function of the molecular geometry of its surfactant molecules and solution conditions such as surfactant 
concentration, temperature, pH, and ionic strength. Poly Ethylene Glycol (PEG) is the most commonly used hydrophilic segment of micelles for 
drug delivery. Besides PEG, other polymers including poly (N-vinyl pyrrolidone) (PVP) and poly (N-isopropyl acrylamide) (pNIPAM) have also 
been used as hydrophilic portion of micelles. In this review we all discus about the polymeric micelles (PMs) as a nanocarriers for delivery of 
therapeutic agents. 
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1. Introduction 
A micelle is a colloid formed by a surfactant in equilibrium 
with the molecules or with the ions that contribute at micelle 
formation. In the past decades, nanocarriers have emerged 
as an attractive research field in cancer therapy, including 
liposomes, micelles and nanoparticles made of various 
materials. Polymeric micelles (PMs) are extensively studied 
carriers for the delivery of poorly water-soluble drugs [1] 
Based on the type of intermolecular forces driving the 
micelle formation, block copolymer micelles can be divided 
into several categories including hydrophobically assembled 
amphiphilic micelles, polyion-complex micelles, and micelles 
stemming from metal complexation [2]. The hydrophobically 
assembled micelles usually consist of amphiphilic 
macromolecules that have distinct hydrophobic and 
hydrophilic domains, and the commonly used block 
segments of copolymers have been summarized [3]. Upon 
exposure to aqueous medium, the amphiphilic molecules are 
spontaneously self-assembled into supramolecular 
core/shell structures and water-insoluble drugs can be 
loaded into the hydrophobic cores [4, 5]. 
Micelles have demonstrated a variety of shapes such as 
spheres, rods, vesicles, tubules, and lamellae depending on 
the relative length of hydrophobic/hydrophilic blocks as 
well as solvent environment [6-8]. Morphology of micelles 
has significant impact on the pharmacokinetic properties of 
micelles. For example, worm-like micelles have shown ten 
times longer circulation time compared with the spherical 
counterpart made of similar material [9]. The most 
commonly used hydrophilic segment of micelles for drug 
delivery is poly (ethylene glycol) (PEG), with a molecular 
weight of 2–15 kDa. PEG is highly water-soluble, non-toxic 
and neutrally charged. PEG forms a hydrophilic corona on 
the surface of micelles which minimizes the nonspecific 
interaction with blood components and prolongs the 
circulation time. Besides PEG, other polymers including 
poly(N-vinyl pyrolidone) (PVP) [10] and poly(N-isopropyl 
acrylamide) (pNIPAM) [11] have also been used as 
hydrophilic portion of micelles. 
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Figure 1: Schemetic diagram of micelles formation 
 
2. Formation of Polymeric micelles 
PMs are self-assembled core-shell nanostructures formed in 
an aqueous solution consisting of amphiphilic block 
copolymers [12-14]. Formation of micelles in aqueous 
solution occur when the concentration of the block 
copolymer increases above a certain concentration named 
the critical aggregation concentration (CAC) or critical 
micelle concentration (CMC). At the CAC or CMC, 
hydrophobic segments of block copolymers start to associate 
to minimize the contact with water molecules, leading to the 
formation of a vesicular or core-shell micellar structure. 
Theoretically, the formation of micelles is driven by decrease 
of free energy. The removal of hydrophobic fragments from 
the aqueous environment and the reestablishing of hydrogen 
bond network in water decrease free energy of the system 
and finally form the micelles. The typical methods used for 
encapsulation of poorly water-soluble drugs are dialysis 
method, oil-in-water emulsion solvent evaporation method, 
and solid dispersion method [15, 16]. Other methods used 
are direct dissolution [17, 18], complexation [19], chemical 
conjugation [20], and various solvent evaporation 
procedures [21]. 
 
 
Figure 2: formation of drug loaded micelles 
 
3. pH sensitive PMs 
The potential disadvantage of normal PMs can be solved by 
application of additional stimuli that cause micelle 
destabilization in a specially controlled manner thus 
increasing the selectivity and efficiency of drug delivery to 
target sites. External factors such as heat [22, 23], light [24], 
and sound (ultrasound) [25,26] have already been studied 
by many researchers. However, these external stimuli may 
only activate the carriers that are situated closely 
underneath the skin but not those deeply distributed in the 
body. The intracellular signals also play an important role in 
regulating drug release which causes a great deal of 
interests, and here we focus our attention on pH-responsive 
systems. 
4. Mucoadhesive PMs 
Nanocarriers for oral administration should adhere to 
mucus and cross the mucus layer. Drugs delivered to 
mucosal surfaces are usually efficiently removed by mucus 
clearance mechanisms [27]. The luminal surface of mucosal 
tissues is protected by a highly viscoelastic layer [28], and 
the protective coatings rapidly remove foreign particles 
from the GI tract which probably lead to low bioavailability. 
Unlike the relatively high requirements of intravenous 
infusions, oral formulations could include high-molecular 
weight polymers as long as these components are 
metabolizable and cannot find their way into the systemic 
circulation. Hence, it may be an effective means of increasing 
uptake of drugs with mucoadhesive PMs [29, 30], and there 
have been considerable interests in the concept of 
mucoadhesive PMs.  
5. Micelles with built-in drug-interactive domain 
as improved delivery systems  
The drug-loading capacity of polymeric micelles is critically 
dependent on the compatibility between the drug and the 
micelle core [31]. A series of studies have demonstrated that 
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the drug-loading capacity of micelles can be greatly 
enhanced by optimizing chemical structures of the inner 
core segment for stronger drug/carrier interaction. A typical 
example of the strategy for enhanced compatibility between 
drug and block copolymer is the development of hydrotropic 
polymers. Hydrotropy refers to a phenomenon that the 
aqueous solubility of a poorly soluble compound is 
significantly enhanced by the presence of large amounts of a 
second solute, named hydrotrope [32]. The hydrotropes 
aggregate only above a certain concentration, which is 
known as the minimal hydrotrope concentration (MHC) 
[33]. Various studies have been carried out to elucidate the 
process of hydrotropic solubilization. Although the exact 
mechanism is not fully clarified, it may involve multiple non-
covalent interactions including hydrophobic interaction, 
hydrogen bonding [30] as well as parallel stacking effect 
[34, 35]. 
 
6. PEG-drug conjugates as dual-function carriers 
for cancer targeted delivery 
PEG-Vitamin E Conjugates as Dual-Function Carriers for 
Cancer-Targeted Delivery D-α-tocopheryl polyethylene 
glycol (PEG) 1,000 succinate (TPGS) is a PEG-derivatized 
natural vitamin E which has been approved by FDA as a safe 
pharmaceutical adjuvant for drug formulation. In recent 
years, the application of TPGS in drug formulations has been 
extensively studied, such as emulsifier in poly (lactic-co-
glycolic acid) (PLGA) nanoparticles, solubilizer and 
permeation enhancer [36], TPGS based liposomes [37], 
copolymers [38], and nanocrystal [39]. By inhibiting the 
function of P-glycoprotein (P-gp), TPGS also helps to 
overcome the multidrug resistance [40] and enhance the 
oral bioavailability of anticancer drugs [41]. In addition, 
TPGS-doxorubicin conjugate was develop ed as a prodrug for 
enhanced therapeutic effect [42]. 
 
 
Figure 3: Preparation scheme for folic acid conjugated TPGS2k micelles loaded with Docetaxel as a model drug. 
 
7. PEG-derivatized Embelin as a nanocarrier  
Bearing a long lipophilic chain, embelin is extremely 
hydrophobic and water-insoluble. In an attempt to explore 
the PEG modification as an approach to increase its water 
solubility, we have found that PEG-derivatized embelin 
forms micelles in aqueous solution [43]. This is not a 
surprise considering the structural similarity between 
embelin and vitamin E. Interestingly, the antitumor activity 
of embelin was well retained after coupling with PEG chain 
[43]. In addition, the PEG-embelin micelles are highly 
efficient in solubilizing various types of anticancer agent 
such as paclitaxel [43, 44]. Furthermore, PEG-embelin, at 
nanomolar range, showed synergistic effect with paclitaxel 
in several cancer cell lines tested [45] 
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8. Conclusion 
Overall study revealed that the polymeric micelles have 
potential to be act as a targeted nanocarrier for delivery of 
various therapeutic agents. Hence polymeric micelles can be 
used for the drug delivery application. 
References 
1. Yifei Zhang, Yixian Huang, and Song Li .,Polymeric Micelles: 
Nanocarriers for Cancer-Targeted Drug Delivery  
2. Gaucher G, Dufresne MH, Sant VP, Kang N, Maysinger D, 
Leroux JC. Block copolymer micelles: preparation, 
characterization and application in drug delivery. J Control 
Release. 2005; 109(1–3):169–88.  
3. Sutton D, Nasongkla N, Blanco E, Gao J. Functionalized 
micellar systems for cancer targeted drug delivery. Pharm 
Res. 2007; 24(6):1029–46.  
4. Rarokar NR, Khedekar PB, Formulation and evaluation of 
docetaxel trihydrate loaded self-assembled nanocarriers for 
treatment of HER2 positive breast cancer. Journal of drug 
delivery and Therapeutics.  2017; 7(6):1-6 
5. Rarokar N. R., Khedekar P. B., Bharne A., Umekar M.,  
Development of self-assembled nanocarriers to enhance 
antitumor efficacy of docetaxel trihydrate in MDA-MB-231 cell 
line, Int. J. Biol. Macromol. 125 (2019) 1056-1068. 
DOI:doi.org/10.1016/j.ijbiomac.2018.12.130 
6. Choucair A, Eisenberg A. Control of amphiphilic block 
copolymer morphologies using solution conditions. Eur Phys J 
E Soft Matter. 2003; 10(1):37–44.  
7. Yu Y, Zhang L, Eisenberg A. Morphogenic effect of solvent on 
crew-cut aggregates of amphiphilic diblock copolymers. 
Macromolecules. 1998; 31(4):1144–54.  
8. Shen H, Zhang L, Eisenberg A. Multiple pH-induced 
morphological changes in aggregates of polystyrene-block-
poly(4-vinylpyridine) in DMF/H2O mixtures. J Am Chem Soc. 
1999; 121(12):2728–40.  
9. Geng Y, Dalhaimer P, Cai S, Tsai R, Tewari M, Minko T, et al. 
Shape effects of filaments versus spherical particles in flow 
and drug delivery. Nat Nanotechnol. 2007; 2(4):249–55.  
10. Benahmed A, Ranger M, Leroux JC. Novel polymeric micelles 
based on the amphiphilic diblock copolymer poly(N-vinyl-2- 
pyrrolidone)-block-poly(D, L-lactide). Pharm Res. 2001; 
18(3):3238.  
11. Chung JE, Yokoyama M, Aoyagi T, Sakurai Y, Okano T. Effect of 
molecular architecture of hydrophobically modified 
poly(Nisopropylacrylamide) on the formation of 
thermoresponsive core-shell micellar drug carriers. J Control 
Release. 1998; 53(1– 3):119–30. 
12. Riess G., “Micellization of block copolymers,” Progress in 
Polymer Science, vol. 28, no. 7, pp. 1107–1170, 2003. View at 
Publisher · View at Google Scholar · View at Scopus 
13. Jones M.-C. and J.-C. Leroux, “Polymeric micelles—a new 
generation of colloidal drug carriers,” European Journal of 
Pharmaceutics and Biopharmaceutics, vol. 48, no. 2, pp. 101–
111, 1999. View at Publisher · View at Google Scholar · View 
at Scopus 
14. Rarokar N.R., Saoji S.D., Khedekar P.B., Investigation of 
effectiveness of some extensively used polymers on 
thermoreversible properties of Pluronic® tri-block 
copolymers, J. Drug Delivery Sci. Technol. 44 (2018) 220–230. 
DOI:doi.org/10.1016/j.jddst.2017.12.002 
15. Van Butsele K., Sibret P., Fustin C. A. et al., “Synthesis and pH-
dependent micellization of diblock copolymer 
mixtures,” Journal of Colloid and Interface Science, vol. 329, 
no. 2, pp. 235–243, 2009. View at Publisher · View at Google 
Scholar · View at Scopus 
16. Parajapati SK, Maurya SD, Das MK, Tilak VK, Verma KK, 
Dhakar RC, Potential application of dendrimers in drug 
delivery: A concise review and update, Journal of Drug 
Delivery and Therapeutics 2016; 6(2):71-88 
17. Alakhov V. Y., Moskaleva E. Y., Batrakova E. V., and A. V. 
Kabanov, “Hypersensitization of multidrug resistant human 
ovarian carcinoma cells by pluronic P85 block 
copolymer,” Bioconjugate Chemistry, vol. 7, no. 2, pp. 209–
216, 1996. View at Google Scholar · View at Scopus . 
18. Rarokar N.R., S.D. Saoji, N.A. Raut, J.B. Taksande, P.B. 
Khedekar, V.S. Dave, Nanostructured cubosomes in a 
thermoresponsive depot system: an alternative approach for 
the controlled delivery of docetaxel, AAPS PharmSciTech 17 
(2015) 436–445. DOI:10.1208/s12249-015-0369-y 
19. Nishiyama N., Kataoka K., “Preparation and characterization 
of size-controlled polymeric micelle containing cis-
dichlorodiammineplatinum(II) in the core,” Journal of 
Controlled Release, vol. 74, no. 1-3, pp. 83–94, 2001. View at 
Publisher · View at Google Scholar · View at Scopus 
20. Y. Li and G. S. Kwon, “Methotrexate esters of poly(ethylene 
oxide)-block-poly(2-hydroxyethyl-L- aspartamide). Part I: 
effects of the level of methotrexate conjugation on the 
stability of micelles and on drug release,” Pharmaceutical 
Research, vol. 17, no. 5, pp. 607–611, 2000. View at 
Publisher · View at Google Scholar · View at Scopus . 
21. Lavasanifar A., Samuel J., and G. S. Kwon, “Micelles self-
assembled from poly(ethylene oxide)-block-poly(N-hexyl 
stearate L-aspartamide) by a solvent evaporation method: 
effect on the solubilization and haemolytic activity of 
amphotericin B,” Journal of Controlled Release, vol. 77, no. 1-
2, pp. 155–160, 2001. View at Publisher · View at Google 
Scholar · View at Scopus 
22. Tan R., She Z., M. Wang, Z. Fang, Y. Liu, and Q. Feng, “Thermo-
sensitive alginate-based injectable hydrogel for tissue 
engineering,” Carbohydrate Polymers, vol. 87, no. 2, pp. 1515–
1521, 2012. View at Publisher · View at Google Scholar · View 
at Scopus . 
23. Liu G., X. Li, S. Xiong et al., “Fluorine-containing thermo-
sensitive core/shell microgel particles: preparation, 
characterization, and their applications in controlled drug 
release,” Journal of Fluorine Chemistry, vol. 135, pp. 75–82, 
2012. View at Publisher · View at Google Scholar · View at 
Scopus 
24. Chen C. J., Q. Jin, G. Y. Liu, D. D. Li, J. L. Wang, and J. Ji, 
“Reversibly light-responsive micelles constructed via a simple 
modification of hyperbranched polymers with 
chromophores,” Polymer, vol. 53, no. 17, pp. 3695–3703, 
2012. View at Publisher · View at Google Scholar 
25. Husseini G. A., Velluto D., L. Kherbeck, W. G. Pitt, J. A. Hubbell, 
and D. A. Christensen, “Investigating the acoustic release of 
doxorubicin from targeted micelles,” Colloids and Surfaces B, 
vol. 101, pp. 153–155, 2013. View at Publisher · View at 
Google Scholar 
26. Yin T., Wang P., Li J. et al., “Ultrasound-sensitive siRNA-loaded 
nanobubbles formed by hetero-assembly of polymeric 
micelles and liposomes and their therapeutic effect in 
gliomas,” Biomaterials, vol. 34, no. 18, pp. 4532–4543, 
2013. View at Publisher · View at Google Scholar . 
27. Tang B. C., Dawson M., Lai S. K. et al., “Biodegradable polymer 
nanoparticles that rapidly penetrate the human mucus 
barrier,” Proceedings of the National Academy of Sciences of 
the United States of America, vol. 106, no. 46, pp. 19268–
19273, 2009. View at Publisher · View at Google 
Scholar · View at Scopus . 
28. Cone R. A., “Barrier properties of mucus,” Advanced Drug 
Delivery Reviews, vol. 61, no. 2, pp. 75–85, 2009. View at 
Publisher · View at Google Scholar · View at Scopus 
29. Rahmat D., Muller C., Barthelmes J., Shahnaz G., R. Martien, and 
Schnurch A. B., “Thiolated hydroxyethyl cellulose: design and 
in vitro evaluation of mucoadhesive and permeation 
enhancing nanoparticles,” European Journal of Pharmaceutics 
and Biopharmaceutics, vol. 83, no. 2, pp. 149–155, 2013. View 
at Publisher · View at Google Scholar 
30. Srivalli K. M. R., Lakshmi P. K., and Balasubramaniam J., “Design 
of a novel bilayered gastric mucoadhesive system for localized 
and unidirectional release of lamotrigine,” Saudi 
Pharmaceutical Journal, vol. 21, no. 1, pp. 45–52, 2013. View 
at Publisher · View at Google Scholar · View at Scopus 
31. Latere Dwan’Isa JP, Rouxhet L, Preat V, Brewster ME, Arien A. 
Prediction of drug solubility in amphiphilic di-block 
copolymer micelles: the role of polymer-drug compatibility. 
Pharmazie. 2007;62(7):499–504.  
32. Coffman R, Kildsig D. Hydrotropic solubilization—mechanistic 
studies. Pharm Res. 1996; 13(10):1460–3.  
33. Bauduin P, Renoncourt A, Kopf A, Touraud D, Kunz W. Unified 
concept of solubilization in water by hydrotropes and 
cosolvents. Langmuir. 2005; 21(15):6769–75. 
Agrawal et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2020; 10(1-s):191-195 
ISSN: 2250-1177                                                                                  [195]                                                                                 CODEN (USA): JDDTAO 
34. Kim JY, Kim S, Papp M, Park K, Pinal R. Hydrotropic 
solubilization of poorly water-soluble drugs. J Pharm Sci. 
2010; 99(9):3953–65. 
35. Cui Y. Parallel stacking of caffeine with riboflavin in aqueous 
solutions: the potential mechanism for hydrotropic 
solubilization of riboflavin. Int J Pharm. 2010; 397(1–2):36–
43. 
36. Ooya T, Lee S, Huh K, Park K. Hydrotropic nanocarriers for 
poorly soluble drugs. In: Mozafari MR, editor. Nanocarrier 
technologies. Netherlands: Springer; 2006. p. 51–73. 
37. Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A, et al. Vitamin 
E-TPGS increases absorption flux of an HIV protease inhibitor 
by enhancing its solubility and permeability. Pharm Res. 
1999; 16(12):1812–7.  
38. Muthu MS, Kulkarni SA, Xiong J, Feng SS. Vitamin E TPGS 
coated liposomes enhanced cellular uptake and cytotoxicity of 
docetaxel in brain cancer cells. Int J Pharm. 2011; 
421(2):332–40.  
39. Zhang Z, Feng SS. Nanoparticles of poly(lactide)/vitamin E 
TPGS copolymer for cancer chemotherapy: synthesis, 
formulation, characterization and in vitro drug release. 
Biomaterials. 2006; 27(2):262–70.  
40. Liu Y, Huang L, Liu F. Paclitaxel nanocrystals for overcoming 
multidrug resistance in cancer. Mol Pharm. 2010;7(3):863–9. 
41. Cheng X, Developing organic and inorganic nanomedicine for 
cancer therapy, Journal of Drug Delivery and Therapeutics. 
2017; 7(2):1-4 
42. Varma MV, Panchagnula R. Enhanced oral paclitaxel absorption 
with vitamin E-TPGS: effect on solubility and permeability in 
vitro, in situ and in vivo. Eur J Pharm Sci. 2005; 25(4–5):445– 
53. 
43. Cao N, Feng SS. Doxorubicin conjugated to D-alpha-tocopheryl 
polyethylene glycol 1000 succinate (TPGS): conjugation 
chemistry, characterization, in vitro and in vivo evaluation. 
Biomaterials. 2008; 29(28):3856–65. 
44. Huang Y, Lu J, Gao X, Li J, Zhao W, Sun M, et al. PEGderivatized 
embelin as a dual functional carrier for the delivery of 
paclitaxel. Bioconjug Chem. 2012; 23(7):1443–51.  
45. Lu J, Huang Y, Zhao W, Marquez RT, Meng X, Li J, et al. 
PEGderivatized embelin as a nanomicellar carrier for delivery 
of paclitaxel to breast and prostate cancers. Biomaterials. 
2013; 34(5):1591–600. 
 
 
 
 
